486 related articles for article (PubMed ID: 29362432)
1. Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis.
Zhang Z; Qu J; Zheng C; Zhang P; Zhou W; Cui W; Mo X; Li L; Xu L; Gao J
Cell Death Dis; 2018 Jan; 9(2):83. PubMed ID: 29362432
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis.
Zhou W; Mo X; Cui W; Zhang Z; Li D; Li L; Xu L; Yao H; Gao J
Sci Rep; 2016 Dec; 6():38646. PubMed ID: 27982105
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of HMGB1 is required for the protective role of Nrf2 in EMT-mediated PF.
Qu J; Zhang Z; Zhang P; Zheng C; Zhou W; Cui W; Xu L; Gao J
J Cell Physiol; 2019 Jun; 234(6):8862-8872. PubMed ID: 30370641
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation.
Yan B; Ma Z; Shi S; Hu Y; Ma T; Rong G; Yang J
Mol Med Rep; 2017 Jun; 15(6):4005-4014. PubMed ID: 28487960
[TBL] [Abstract][Full Text] [Related]
5. Atractylenolide III attenuates bleomycin-induced experimental pulmonary fibrosis and oxidative stress in rat model via Nrf2/NQO1/HO-1 pathway activation.
Huai B; Ding J
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):436-444. PubMed ID: 32762376
[TBL] [Abstract][Full Text] [Related]
6. Inositol-requiring protein 1 - X-box-binding protein 1 pathway promotes epithelial-mesenchymal transition via mediating snail expression in pulmonary fibrosis.
Mo XT; Zhou WC; Cui WH; Li DL; Li LC; Xu L; Zhao P; Gao J
Int J Biochem Cell Biol; 2015 Aug; 65():230-8. PubMed ID: 26065400
[TBL] [Abstract][Full Text] [Related]
7. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
9. COX-2/sEH Dual Inhibitor PTUPB Attenuates Epithelial-Mesenchymal Transformation of Alveolar Epithelial Cells
Zhang CY; Guan XX; Song ZH; Jiang HL; Liu YB; Chen P; Duan JX; Zhou Y
Oxid Med Cell Longev; 2022; 2022():5759626. PubMed ID: 35509835
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling.
Feng F; Cheng P; Xu S; Li N; Wang H; Zhang Y; Wang W
Chem Biol Interact; 2020 Mar; 319():109024. PubMed ID: 32097614
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Notch-1/Twist-1 axis in the process of epithelial-mesenchymal transition of type II alveolar epithelial cell and its mechanism].
Tang J; Ke J; Fu Y; He XW; Li XW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):577-583. PubMed ID: 34821087
[No Abstract] [Full Text] [Related]
12. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
13. Chelerythrine Ameliorates Pulmonary Fibrosis via Activating the Nrf2/ARE Signaling Pathway.
Peng L; Wen L; Shi Q; Gao F; Huang B; Wang C
Cell Biochem Biophys; 2021 Jun; 79(2):337-347. PubMed ID: 33580396
[TBL] [Abstract][Full Text] [Related]
14. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways.
Tang H; Gao L; Mao J; He H; Liu J; Cai X; Lin H; Wu T
Cell Stress Chaperones; 2016 Mar; 21(2):239-49. PubMed ID: 26577463
[TBL] [Abstract][Full Text] [Related]
15. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.
Han YY; Gu X; Yang CY; Ji HM; Lan YJ; Bi YQ; Si R; Qu J; Cheng MH; Gao J
J Cell Physiol; 2021 Nov; 236(11):7734-7744. PubMed ID: 34061990
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal assessment of bleomycin-induced pulmonary fibrosis by evaluating TGF-β1/Smad2, Nrf2 signaling and metabolomic analysis in mice.
Washimkar KR; Tomar MS; Kulkarni C; Verma S; Shrivastava A; Chattopadhyay N; Mugale MN
Life Sci; 2023 Oct; 331():122064. PubMed ID: 37657527
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
20. 4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition.
Wu YX; Zhang YR; Jiang FJ; He S; Zhang YL; Chen D; Tong Y; Nie YJ; Pang QF
Inflamm Res; 2023 Jun; 72(6):1133-1145. PubMed ID: 37169970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
